Can iron deficiency raise HbA1c independently of average blood glucose?

Iron deficiency is a recognized clinical confounder that can lead to misleadingly elevated HbA1c levels, which may not accurately reflect a patient's true average blood glucose. This relationship is particularly relevant in women and individuals at risk for iron deficiency anemia (IDA), as it can result in the overdiagnosis of pre-diabetes or diabetes.

Clinical effectiveness and impact

Clinical data consistently show that iron deficiency increases HbA1c levels in the absence of elevated plasma glucose.

• HbA1c Elevation: A meta-analysis involving 3,016 non-diabetic individuals (SMD 0.81) and targeted studies of 120 non-diabetic adults confirm that iron deficiency anemia is associated with significantly higher HbA1c baseline levels (mean 6.0% vs. 5.5% in iron-replete individuals).
• Reversibility with Treatment: Iron supplementation therapy (oral or intravenous) has been shown to reduce HbA1c levels significantly. In one study, three months of iron therapy reduced mean HbA1c from 6.0% to 5.5% (p < 0.001) without any change in fasting glucose or diet.
• Diagnostic Sensitivity: Because iron deficiency is common (especially in premenopausal women), relying solely on HbA1c without assessing iron status (ferritin, transferrin saturation) may lead to misinterpretation of glycemic control.

Mechanistic explanations

The elevation of HbA1c in iron deficiency is primarily driven by changes in red blood cell (RBC) kinetics and the glycation environment.

• Reduced Erythropoiesis: Iron deficiency impairs the production of new red blood cells. When fewer new cells enter circulation, the average age of the existing RBC population increases.
• Cumulative Glycation: Since HbA1c measures the cumulative attachment of glucose to hemoglobin over a cell's life, these "older" RBCs have been exposed to circulating glucose for a longer duration, resulting in a higher percentage of glycation regardless of the actual glucose concentration.
• Molecular Kinetics: There is secondary evidence suggesting that iron deficiency may alter the structural configuration of hemoglobin or increase oxidative stress (the malondialdehyde pathway), which could further accelerate the non-enzymatic glycation of the hemoglobin molecule.

Bottom line

Iron deficiency can spuriously elevate HbA1c levels by increasing the average age of circulating red blood cells, leading to longer glucose exposure. In patients with unexplained HbA1c elevations or those at risk for anemia, iron status should be evaluated to ensure accurate assessment of long-term glycemic control.